Risk-Guided Statin Initiation in People Living with HIV: Clinical Utility of a Cardiovascular Risk Prediction Model in a Malaysian Cohort
Journal of the International Association of Providers of AIDS Care (JIAPAC) · 2026
DOI: 10.1177/23259582261492596 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the International Association of Providers of AIDS Care (JIAPAC), 2026. Verfasst von Wen Yea Hwong und 2 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Clinical Epidemiology, Institute for Clinical Research, National Institutes of Health, Ministry of Health Malaysia, Shah Alam, Selangor, M…. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, HIV Infections, Cardiovascular Diseases. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Kementerian Kesihatan Malaysia.
Abstract (Originalsprache)
Background
Optimal statin initiation strategies for people living with HIV (PLHIV) remain uncertain. We evaluated whether the D:A:D reduced (D:A:Dr) model improves primary prevention statin initiation decisions among Malaysian PLHIV compared with non-risk-based strategies.
Methods
This retrospective cohort study followed statin-naïve PLHIV adults from an infectious diseases centre over five years for incident cardiovascular events. Decision curve analysis compared the net benefit of a D:A:Dr-guided strategy against four alternatives: LDL-cholesterol ≥3.0 mmol/L, age ≥40 years, treat-all, and treat-none.
Results
Among 5,741 PLHIV, 48.9% were moderate-to high-risk. The 5-year event rate was 2.0%, ranging from 0.5% (low-risk) to 8–9% (high-risk). D:A:Dr-guided strategy yielded superior net benefit at >2% - 10% threshold probabilities. Age ≥40 years lost benefits as thresholds increased whereas LDL–cholesterol–based strategy offered minimal utility.
Conclusion
D:A:Dr risk-based statin initiation offers superior clinical utility at >2% to 10% threshold probabilities, enabling targeted, resource-efficient prescribing in resource-constrained settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Clinical Epidemiology, Institute for Clinical Research, National Institutes of Health, Ministry of Health Malaysia, Shah Alam, Selangor, Malaysia.
- Department of Internal Medicine, Sungai Buloh Hospital, Ministry of Health Malaysia, Selangor, Malaysia.
ORCID-Profile: Wen Yea Hwong
Förderung
- Kementerian Kesihatan Malaysia
Zitieren
APA
Hwong, W. Y., Teh, H. S., & Tay, K. H. (2026). Risk-Guided Statin Initiation in People Living with HIV: Clinical Utility of a Cardiovascular Risk Prediction Model in a Malaysian Cohort. Journal of the International Association of Providers of AIDS Care (JIAPAC). https://doi.org/10.1177/23259582261492596
Vancouver
Hwong WY, Teh HS, Tay KH. Risk-Guided Statin Initiation in People Living with HIV: Clinical Utility of a Cardiovascular Risk Prediction Model in a Malaysian Cohort. Journal of the International Association of Providers of AIDS Care (JIAPAC). 2026. doi:10.1177/23259582261492596
BibTeX
@article{Hwong2026,
author = {Hwong, Wen Yea and Teh, Hoon Shien and Tay, Kim Heng},
title = {Risk-Guided Statin Initiation in People Living with HIV: Clinical Utility of a Cardiovascular Risk Prediction Model in a Malaysian Cohort},
journal = {Journal of the International Association of Providers of AIDS Care (JIAPAC)},
year = {2026},
doi = {10.1177/23259582261492596}
}
EUVIMED